These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31462310)

  • 1. Si-ni-tang (a Chinese herbal formula) for improving immunofunction in sepsis: study protocol for a pilot randomized controlled trial.
    Zeng R; Zheng Y; Fan R; Zhou G; Zhang Y; Mai S; Xie D; Weng Y; Du J; Han Y; Lai F
    Trials; 2019 Aug; 20(1):537. PubMed ID: 31462310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous use of traditional Chinese medicine (si-ni-tang) to treat septic shock patients: study protocol for a randomized controlled trial.
    Chen HC; Chen WC; Lin KH; Chen YH; Lo LC; Lee TC; Hsia TC; Wang CH; Wu SH; Hsu HW; Chang YJ; Huang YC; Ku TH; Horng MH
    Trials; 2011 Aug; 12():199. PubMed ID: 21864392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial.
    Wu J; Zhou L; Liu J; Ma G; Kou Q; He Z; Chen J; Ou-Yang B; Chen M; Li Y; Wu X; Gu B; Chen L; Zou Z; Qiang X; Chen Y; Lin A; Zhang G; Guan X
    Crit Care; 2013 Jan; 17(1):R8. PubMed ID: 23327199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of Xuebijing injection and its influence on immunomodulation in acute exacerbations of chronic obstructive pulmonary disease: study protocol for a randomized controlled trial.
    Xie S; Yan P; Yao C; Yan X; Huo Y; Zhang J; Liu S; Feng Z; Shang H; Xie L
    Trials; 2019 Feb; 20(1):136. PubMed ID: 30777117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se).
    Zimmermann JB; Pinder N; Bruckner T; Lehmann M; Motsch J; Brenner T; Hoppe-Tichy T; Swoboda S; Weigand MA; Hofer S
    Trials; 2017 Nov; 18(1):530. PubMed ID: 29126416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bai Hu Tang, Si Ni Tang, and Xue Bi Tang amplify pro-inflammatory activities and reduce apoptosis in endothelial cells in a cell culture model of sepsis.
    Brislinger D; Daxböck C; Roßmanith E; Stückler M; Lang I; Falkenhagen D
    J Ethnopharmacol; 2018 Oct; 225():309-318. PubMed ID: 30036577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of Sipjeondaebo-tang in Korean patients with cold hypersensitivity in the hands and feet: a protocol for a pilot, randomized, double-blind, placebo-controlled, parallel-group clinical trial.
    Ko Y; Sun SH; Han IS; Go HY; Kim TH; Lee JM; Jang JB; Park KS; Song YK; Lee KY; Jeon CY; Ko SG
    Trials; 2019 Apr; 20(1):217. PubMed ID: 30987667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of Danggui-Sayuk-Ga-Osuyu-Saenggang-tang on Korean patients with cold hypersensitivity in the hands: study protocol for a pilot, double-blind, randomized, placebo-controlled, parallel-group clinical trial.
    Ko Y; Go HY; Cho YY; Shin JH; Kim TH; Choi DJ; Lee JM; Jang JB; Song YK; Ko SG; Sun SH; Jeon CY
    Trials; 2017 Jun; 18(1):268. PubMed ID: 28595610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness and safety of Kami Guibi-tang for mild cognitive impairment: study protocol of a pilot, randomized, placebo-controlled, double-blind trial.
    Shin HY; Kim JH; Jahng GH; Jung WS; Park SU; Ko CN; Park JM
    Trials; 2019 Jul; 20(1):448. PubMed ID: 31331367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of Yukgunja-Tang for treating anorexia in patients with cancer: The protocol for a pilot, randomized, controlled trial.
    Kang HJ; Jeong MK; Park SJ; Jun HJ; Yoo HS
    Medicine (Baltimore); 2019 Oct; 98(40):e16950. PubMed ID: 31577697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of acupuncture and Chinese herbal formula for elderly adults with mild cognitive impairment: protocol for a randomized controlled trial.
    Chen Y; Zhang W; Wu H; Lao L; Xu J; Xu S
    Trials; 2019 Feb; 20(1):117. PubMed ID: 30744676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese herbal medicine bi min fang for allergic rhinitis: protocol for a double-blind, double-dummy, randomized controlled trial.
    Luo Q; Zhou S; Li X; Chen Q; Lin W; Lu L; Li H; Chen C; Chen W; Li Y
    Trials; 2019 Jan; 20(1):66. PubMed ID: 30658660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral granulated Chinese herbal medicine (YXBCM01) plus topical calcipotriol for psoriasis vulgaris: study protocol for a double-blind, randomized placebo controlled trial.
    Parker S; Zhang AL; Zhang CS; Goodman G; Wen Z; Lu C; Xue CC
    Trials; 2014 Dec; 15():495. PubMed ID: 25526951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial).
    Zhou Z; Feng T; Xie Y; Huang P; Xie H; Tian R; Qian B; Wang R
    BMC Infect Dis; 2019 Sep; 19(1):780. PubMed ID: 31492102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADJunctive Ulinastatin in Sepsis Treatment in China (ADJUST study): study protocol for a randomized controlled trial.
    Jiang W; Yu X; Sun T; Chai Y; Chang P; Chen Z; Pan J; Peng Z; Wang R; Wang X; Xu Y; Yu L; Zheng Q; Du B;
    Trials; 2018 Feb; 19(1):133. PubMed ID: 29467017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Euiiyin-tang in the treatment of obesity: study protocol for a randomised controlled trial.
    Cheon C; Jang S; Park JS; Ko Y; Kim DS; Lee BH; Song HJ; Song YK; Jang BH; Shin YC; Ko SG
    Trials; 2017 Jun; 18(1):289. PubMed ID: 28637494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanxinjing capsule in the treatment of chronic stable angina: study protocol for a randomized controlled trial.
    Tian Y; Zhang J; Zhao Y; Mao J; Zhu L; Gao R; Wang X; Zhu M; Ma L; Zhao M; Zheng W
    Trials; 2018 Oct; 19(1):577. PubMed ID: 30342551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised placebo-controlled trial of a traditional Chinese herbal formula in the treatment of primary dysmenorrhoea.
    Yeh LL; Liu JY; Lin KS; Liu YS; Chiou JM; Liang KY; Tsai TF; Wang LH; Chen CT; Huang CY
    PLoS One; 2007 Aug; 2(8):e719. PubMed ID: 17710126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized medicine with IgGAM compared with standard of care for treatment of peritonitis after infectious source control (the PEPPER trial): study protocol for a randomized controlled trial.
    Kalvelage C; Zacharowski K; Bauhofer A; Gockel U; Adamzik M; Nierhaus A; Kujath P; Eckmann C; Pletz MW; Bracht H; Simon TP; Winkler M; Kindgen-Milles D; Albertsmeier M; Weigand M; Ellger B; Ragaller M; Ullrich R; Marx G
    Trials; 2019 Mar; 20(1):156. PubMed ID: 30832742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Xuebijing Injection for Sepsis (EXIT-SEP): protocol for a randomised controlled trial.
    Liu S; Yao C; Zhang J; Yang Y; Qiu H;
    BMJ Open; 2019 Aug; 9(8):e028664. PubMed ID: 31467049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.